Sera Prognostics, Inc. (SERA)
USD 3.34
(2.77%)
USD 3.34
(2.77%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 840 Thousand USD | -54.55% |
| 2022 | 1.84 Million USD | 3322.22% |
| 2021 | 54 Thousand USD | -88.63% |
| 2020 | 475 Thousand USD | -91.48% |
| 2019 | 5.57 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 568 Thousand USD | 0.0% |
| 2024 Q2 | 351 Thousand USD | 0.0% |
| 2023 Q4 | 840 Thousand USD | -23.71% |
| 2023 Q2 | 1.36 Million USD | -15.0% |
| 2023 FY | 840 Thousand USD | -54.55% |
| 2023 Q1 | 1.6 Million USD | -13.42% |
| 2023 Q3 | 1.1 Million USD | -19.04% |
| 2022 Q2 | 848 Thousand USD | 18.11% |
| 2022 FY | 1.84 Million USD | 3322.22% |
| 2022 Q1 | 718 Thousand USD | 1229.63% |
| 2022 Q3 | 735 Thousand USD | -13.33% |
| 2022 Q4 | 1.84 Million USD | 151.43% |
| 2021 Q2 | 91 Thousand USD | -80.09% |
| 2021 Q3 | 73 Thousand USD | -19.78% |
| 2021 Q4 | 54 Thousand USD | -26.03% |
| 2021 FY | 54 Thousand USD | -88.63% |
| 2021 Q1 | 457 Thousand USD | -3.79% |
| 2020 FY | 475 Thousand USD | -91.48% |
| 2020 Q4 | 475 Thousand USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2019 FY | 5.57 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Aspira Women's Health Inc. | 1.43 Million USD | 41.259% |
| bioAffinity Technologies, Inc. | 1.11 Million USD | 24.897% |
| Intelligent Bio Solutions Inc. | 81.32 Thousand USD | -932.905% |
| Standard BioTools Inc. | 3.98 Million USD | 78.91% |
| Inotiv, Inc. | 399.4 Million USD | 99.79% |
| Prenetics Global Limited | 867.21 Thousand USD | 3.138% |
| Neuronetics, Inc. | 59.28 Million USD | 98.583% |
| Star Equity Holdings, Inc. | 1.14 Million USD | 26.638% |
| Castle Biosciences, Inc. | 14.19 Million USD | 94.084% |
| Psychemedics Corporation | 945 Thousand USD | 11.111% |
| RadNet, Inc. | 812.06 Million USD | 99.897% |
| Exact Sciences Corporation | 2.47 Billion USD | 99.966% |
| IDEXX Laboratories, Inc. | 622.88 Million USD | 99.865% |
| iSpecimen Inc. | 29.13 Thousand USD | -2783.625% |
| OpGen, Inc. | 2.02 Million USD | 58.449% |
| Exagen Inc. | 19.23 Million USD | 95.632% |
| Bionano Genomics, Inc. | 7.17 Million USD | 88.293% |
| CareDx, Inc | 28.27 Million USD | 97.029% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Twist Bioscience Corporation | 79.17 Million USD | 98.939% |
| Guardant Health, Inc. | 1.13 Billion USD | 99.926% |
| Biodesix, Inc. | 35.22 Million USD | 97.615% |
| BioNexus Gene Lab Corp. | 98.76 Thousand USD | -750.521% |
| Precipio, Inc. | 106 Thousand USD | -692.453% |
| Natera, Inc. | 282.94 Million USD | 99.703% |
| Fulgent Genetics, Inc. | 10.11 Million USD | 91.692% |
| 23andMe Holding Co. | 67.84 Million USD | 98.762% |
| OPKO Health, Inc. | 222.03 Million USD | 99.622% |
| Personalis, Inc. | 1.23 Million USD | 31.929% |
| Aclaris Therapeutics, Inc. | 3.07 Million USD | 72.674% |
| Applied DNA Sciences, Inc. | 739.16 Thousand USD | -13.642% |
| T2 Biosystems, Inc. | 6.59 Million USD | 87.269% |
| Neogen Corporation | 888.39 Million USD | 99.905% |
| Myriad Genetics, Inc. | 130.9 Million USD | 99.358% |
| ICON Public Limited Company | 3.66 Billion USD | 99.977% |
| NeoGenomics, Inc. | 606.06 Million USD | 99.861% |
| Star Equity Holdings, Inc. | 1.14 Million USD | 26.638% |
| MDxHealth SA | 35.56 Million USD | 97.638% |
| Prenetics Global Limited | 867.21 Thousand USD | 3.138% |
| Illumina, Inc. | 1.48 Billion USD | 99.944% |
| DarioHealth Corp. | 24.59 Million USD | 96.584% |
| ENDRA Life Sciences Inc. | 192.06 Thousand USD | -337.359% |
| Medpace Holdings, Inc. | 142.12 Million USD | 99.409% |
| Mainz Biomed B.V. | 2.19 Million USD | 61.747% |
| Trinity Biotech plc | 54.65 Million USD | 98.463% |
| Sotera Health Company | 2.22 Billion USD | 99.962% |
| bioAffinity Technologies, Inc. | 1.11 Million USD | 24.897% |